World’s most prescribed COPD treatment goes combo

Boehringer Ingelheim has announced the availability of the first tiotropium-based combination therapy on the PBS for the treatment of chronic obstructive pulmonary disease (COPD). PBS listed from 1 December, Spiolto Respimat combines 5μg of tiotropium and 5μg of olodaterol in the Respimat Soft Mist inhaler. The therapy has been shown to offer improvements beyond tiotropium